“The relationship with Shavit commenced several years before they actually invested in our company. When the time was right, they were ready.”
Uzi Sofer , CEO, Alpha TAU Medical Ltd.
Uzi Sofer , CEO, Alpha TAU Medical Ltd.
Ehud Marom, Mapi Pharma, Chairman & CEO
Shavit Capital is an investment practice that specializes in late-stage investments in Israeli and Israeli-related companies.
Shavit Capital manages five separate private equity funds with over $500 million under management. These Funds invest primarily in companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange. Shavit Capital leads investment rounds that range in size from $20 million to $200 million. These rounds are supported by Shavit’s co-investors including leading international financial institutions.
Shavit Capital also invests in other late-stage opportunities, including bridge rounds of $5 million to $25 million in companies that plan to go public in Israel and other non-US markets.
Gary Leibler is the Founder and Managing Partner of Shavit Capital. The Investment Committee includes Leon Recanati, Jonathan Leibler and Gabriel Menaged.